Stockscreener 앱 받기
1.27
7.97%
-0.11
시간 외 거래:
1.30
0.03
+2.36%
전일 마감가:
$1.38
열려 있는:
$1.35
하루 거래량:
430.64K
Relative Volume:
0.66
시가총액:
$85.26M
수익:
-
순이익/손실:
$-46.12M
주가수익비율:
-1.4696
EPS:
-0.8642
순현금흐름:
$-41.02M
1주 성능:
-15.89%
1개월 성능:
-19.62%
6개월 성능:
-26.59%
1년 성능:
-18.59%
1일 변동 폭
$1.26
$1.355
1주일 범위
$1.26
$1.55
52주 변동 폭
$0.7113
$2.815
Inflarx N V Stock (IFRX) Company Profile
IFRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
1.27 | 93.49M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 재개 | H.C. Wainwright | Buy |
| 2025-05-29 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-02-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-10-28 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-11-06 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | 개시 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-04-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-05 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2019-06-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-01-29 | 개시 | Robert W. Baird | Outperform |
| 2018-12-10 | 개시 | Credit Suisse | Outperform |
| 2018-07-13 | 개시 | BMO Capital Markets | Outperform |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-28 | 개시 | SunTrust | Buy |
| 2018-02-08 | 개시 | B. Riley FBR, Inc. | Buy |
모두보기
Inflarx N V 주식(IFRX)의 최신 뉴스
InflaRx NV expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Perhaps timely catching InflaRx N.V (IFRX) would be a good idea - setenews.com
Why InflaRx N.V. stock remains a top recommendationJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com
Why InflaRx N.V. stock is considered a top pickSwing Trade & Real-Time Market Sentiment Reports - newser.com
InflaRx N.V. stock prediction for this weekJuly 2025 Decliners & Low Drawdown Investment Strategies - newser.com
Will InflaRx N.V. stock see PE expansionWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Will InflaRx N.V. (IF0) stock outperform benchmarksWeekly Trend Summary & Safe Entry Point Alerts - newser.com
Why InflaRx N.V. (IF0) stock benefits from AI revolutionJuly 2025 Trends & Weekly Setup with ROI Potential - newser.com
What hedge fund moves indicate for InflaRx N.V. (IF0) stockTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
Can InflaRx N.V. recover in the next quarter2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Will InflaRx N.V. (IF0) stock deliver compounding returnsJuly 2025 PreEarnings & Real-Time Price Movement Reports - newser.com
What makes InflaRx N.V. stock attractive to growth fundsTrade Exit Report & Verified Swing Trading Watchlists - newser.com
How geopolitical tensions affect InflaRx N.V. stockBear Alert & Risk Managed Investment Strategies - newser.com
Institutional scanner results for InflaRx N.V.Weekly Market Report & Daily Technical Stock Forecast Reports - newser.com
Total debt per share of InflaRx N.V. – MUN:IF0 - TradingView
Reversal indicators forming on InflaRx N.V. stock2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
How InflaRx N.V. stock performs after earningsGap Up & Safe Capital Allocation Plans - newser.com
Volatility clustering patterns for InflaRx N.V.Recession Risk & Technical Pattern Recognition Alerts - newser.com
Should You Watch KEI Industries Limited for Sector Rotation UpsidePrice Momentum Alerts & Unlock Long-Term Capital Growth Ideas - earlytimes.in
InflaRx N.V. (NASDAQ:IFRX) Short Interest Update - MarketBeat
How reliable is InflaRx N.V. (IF0) stock dividend growthIPO Watch & Daily Profit Maximizing Tips - newser.com
Can InflaRx N.V. stock rebound after recent weaknessTrade Volume Summary & Daily Chart Pattern Signals - newser.com
Will InflaRx N.V. (IF0) stock deliver stable dividends2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab - MSN
InflaRx’s Phase 2a Study on INF904: A Potential Game-Changer for Chronic Conditions - MSN
Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment - MSN
InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Inflarx N V (IFRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):